Literature DB >> 24430436

Low HERV-K(C4) copy number is associated with type 1 diabetes.

Mike J Mason1, Cate Speake, Vivian H Gersuk, Quynh-Anh Nguyen, Kimberly K O'Brien, Jared M Odegard, Jane H Buckner, Carla J Greenbaum, Damien Chaussabel, Gerald T Nepom.   

Abstract

Complement component C4 (C4) is a highly variable complement pathway gene situated ∼500 kb from DRB1 and DQB1, the genes most strongly associated with many autoimmune diseases. Variations in C4 copy number (CN), length, and isotype create a highly diverse gene cluster in which insertion of an endogenous retrovirus in the ninth intron of C4, termed HERV-K(C4), is a notable component. We investigated the relationship between C4 variation/CN and type 1 diabetes. We found that individuals with type 1 diabetes have significantly fewer copies of HERV-K(C4) and that this effect is not solely due to linkage with known major histocompatibility complex class II susceptibility alleles. We show that HERV-K(C4) is a novel marker of type 1 diabetes that accounts for the disease association previously attributed to some key HLA-DQB1 alleles, raising the possibility that this retroviral insertion element contributes to functional protection against type 1 diabetes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24430436     DOI: 10.2337/db13-1382

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  18 in total

1.  Type 1 diabetes as an autoimmune disease: the evidence.

Authors:  Stavroula A Paschou; Asimina Petsiou; Katerina Chatzigianni; Agathocles Tsatsoulis; George K Papadopoulos
Journal:  Diabetologia       Date:  2014-04-06       Impact factor: 10.122

2.  A survey of endogenous retrovirus (ERV) sequences in the vicinity of multiple sclerosis (MS)-associated single nucleotide polymorphisms (SNPs).

Authors:  Christine Brütting; Alexander Emmer; Malte Kornhuber; Martin S Staege
Journal:  Mol Biol Rep       Date:  2016-05-12       Impact factor: 2.316

3.  An ancestral retroviral protein identified as a therapeutic target in type-1 diabetes.

Authors:  Sandrine Levet; Julie Medina; Julie Joanou; Amandine Demolder; Nelly Queruel; Kevin Réant; Matthieu Normand; Marine Seffals; Julie Dimier; Raphaële Germi; Thomas Piofczyk; Jacques Portoukalian; Jean-Louis Touraine; Hervé Perron
Journal:  JCI Insight       Date:  2017-09-07

Review 4.  Molecular functions of human endogenous retroviruses in health and disease.

Authors:  Maria Suntsova; Andrew Garazha; Alena Ivanova; Dmitry Kaminsky; Alex Zhavoronkov; Anton Buzdin
Journal:  Cell Mol Life Sci       Date:  2015-06-18       Impact factor: 9.261

Review 5.  Emerging roles for endogenous retroviruses in immune epigenetic regulation.

Authors:  Carmen A Buttler; Edward B Chuong
Journal:  Immunol Rev       Date:  2021-11-23       Impact factor: 12.988

6.  Heterogeneity and Lobularity of Pancreatic Pathology in Type 1 Diabetes during the Prediabetic Phase.

Authors:  Teresa Rodriguez-Calvo; Jessica S Suwandi; Natalie Amirian; Jose Zapardiel-Gonzalo; Florence Anquetil; Somayeh Sabouri; Matthias G von Herrath
Journal:  J Histochem Cytochem       Date:  2015-08       Impact factor: 2.479

7.  Endogenous retrovirus Gag antigen and its gene variants are unique autoantigens expressed in the pancreatic islets of non-obese diabetic mice.

Authors:  Yang D Dai; Peter Dias; Amanda Margosiak; Kristi Marquardt; Roman Bashratyan; Wen-Yuan Hu; Kathryn Haskins; Leonard H Evans
Journal:  Immunol Lett       Date:  2020-04-24       Impact factor: 3.685

Review 8.  Complex and multi-allelic copy number variation in human disease.

Authors:  Christina L Usher; Steven A McCarroll
Journal:  Brief Funct Genomics       Date:  2015-07-09       Impact factor: 4.241

Review 9.  Inside the Envelope: Endogenous Retrovirus-K Env as a Biomarker and Therapeutic Target.

Authors:  Marie-Josée Nadeau; Mamneet Manghera; Renée N Douville
Journal:  Front Microbiol       Date:  2015-11-13       Impact factor: 5.640

Review 10.  The complement system: a gateway to gene-environment interactions in schizophrenia pathogenesis.

Authors:  V L Nimgaonkar; K M Prasad; K V Chowdari; E G Severance; R H Yolken
Journal:  Mol Psychiatry       Date:  2017-08-01       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.